Hoffmann-La Roche Inc.
Hoffmann-La Roche Inc., commonly known as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, with significant operations across North America, Europe, and Asia. The company is renowned for its innovative contributions to oncology, immunology, and infectious diseases, offering a diverse portfolio of prescription medicines and cutting-edge diagnostic tools.
Roche's commitment to research and development has led to numerous breakthroughs, positioning it as a market leader in personalised healthcare. Notable achievements include the development of targeted therapies and advanced diagnostics that enhance patient outcomes. With a strong emphasis on innovation and quality, Hoffmann-La Roche Inc. continues to shape the future of healthcare, making a lasting impact on global health.
+45 vs industry average
Hoffmann-La Roche Inc.’s score of 85 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hoffmann-La Roche Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Hoffmann-La Roche Inc. yet.
Hoffmann-La Roche Inc.'s reported carbon emissions
Hoffmann-La Roche Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Roche Holding AG, which influences its climate commitments and emissions reporting.
As part of its climate strategy, Hoffmann-La Roche Inc. inherits emissions data and reduction targets from Roche Holding AG. However, no specific reduction targets or achievements have been documented for Hoffmann-La Roche Inc. at this time. The company is aligned with industry standards and initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Roche Holding AG.
While specific emissions figures are not provided, Hoffmann-La Roche Inc. is committed to addressing climate change through its parent company's initiatives. The absence of detailed emissions data highlights the need for ongoing transparency and accountability in corporate climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Hoffmann-La Roche Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Hoffmann-La Roche Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Hoffmann-La Roche Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project